Renal cell carcinoma induces significant immune changes that may deteriorate response to immunotherapy

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F99%3A00000040" target="_blank" >RIV/00209805:_____/99:00000040 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Renal cell carcinoma induces significant immune changes that may deteriorate response to immunotherapy

Original language description

Immunological analyses of 79 RCC patient included flow cytometric immunophenotyping of PBMC, estimation of serum cytokine levels of IL-2, IL-4, IL-6, TNF-alpha, sIL-2R and CRP. Concentration of IL-2, sIL-2R and TNF-alpha released by in vitro PHA activated PBMC was assessed in culture medium.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

1999

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Tumour Biology

ISSN

1010-4283

e-ISSN

—

Volume of the periodical

20

Issue of the periodical within the volume

neuv.

Country of publishing house

CH - SWITZERLAND

Number of pages

1

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—